ModoScript
Miami
About ModoScript
At ModoScript we are developing a B2B hardware SaaS remote treatment monitoring big data analytics solution to better remotely assess medication and treatment protocol efficiency to improve positive treatment outcomes. Our focus is in high-price/high-touch specialty pharmaceuticals with a market entry focus in Oral Oncolytics due to the potential benefits of the treatment progress health data collected at enabling the development of more personalized/safer therapies for patients to improve treatment outcomes, at-home quality of care, and reduce costs for industry stakeholders. Our target customers include pharmaceutical companies, health insurance providers, and physician offices/groups/networks. Distribution partners include mail-order specialty pharmacies and in-office medically integrated pharmacies. Our mission is to introduce a customizable data analytics model to improve patient outcomes while enabling the ability to provide access to ModoScript's solution at zero cost to patients. We are committed to providing chronic disease patients with the high-quality remote treatment care that they deserve regardless of race, condition, and socioeconomic status.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.1M
- Funding stage: Seed
- Last round: Non-Equity Assistance (Dec 2023)
- Website: modoscript.com
- Phone: 201-841-7987
Industries & Categories
Analytics, Big Data, Health Care, Medical Device, SaaS
Social Profiles
Canonical: https://fsome.com/organization/modoscript-6375 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.